CYNATA THERAPEUTICS LIMITED - Charts / Financials

0.00%

16.5¢

Market Cap $37.28M

Healthcare Biotechnology

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and... Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.More

RCE'S BREAKTHROUGH

Recce Pharmaceuticals (ASX:RCE) accelerates commercialisation with positive Phase II results.

REFRESH

Day
Open	17.0¢		Day High	17.0¢		Day Low	16.0¢
Daily Volume	176106

Bids				Sellers
Number	Price	Volume		Number	Price	Volume
2	16.0¢	66467		1	17.5¢	65000

Directors & Senior Management

Dr. Kilian Kelly	Chief Executive Officer, Managing Director, Director
Dr. Suzanne Lipe	Vice President - Partner Engagement
Dr. Jolanta Airey	Chief Medical Officer
Dr. Mathias Kroll	Chief Business Officer
Mr. Peter Gordon Webse	Company Secretary
Dr. Geoffrey E. D. Brooke	Independent Non-Executive Chairman of the Board
Ms. Janine Rolfe	Director
Dr. Darryl Maher	Non-Executive Independent Director
Dr. Paul K. Wotton	Non-Executive Independent Director

Data source: Refinitiv

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 16.5¢		Change 0.000(0.00%)		Mkt cap ! $37.28M

Open	High	Low	Value	Volume
17.0¢	17.0¢	16.0¢	$29.18K	176.1K

Buyers (Bids)

No.	Vol.	Price($)
2	66467	16.0¢

Sellers (Offers)

Price($)	Vol.	No.
17.5¢	65000	1

View Market Depth

No.	Vol.	Price($)
2	66467	0.160
4	181490	0.155
5	318045	0.150
4	81775	0.145
4	307863	0.140

Price($)	Vol.	No.
0.175	65000	1
0.185	35419	2
0.190	114978	3
0.195	5764	1
0.200	55400	2

Last trade - 15.59pm 25/07/2025 (20 minute delay)

CYP (ASX) Chart

CYNATA THERAPEUTICS LIMITED - Charts / Financials

Directors & Senior Management

Buyers (Bids)

Sellers (Offers)

Top Stories